Pliant Therapeutics logo

Pliant Therapeutics

Redwood City, CA

Pliant Therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases. By harnessing the therapeutic potential of integrin biology and TGF-β modulation, Pliant aims to prevent or even reverse fibrosis to address the needs of many patients. The company also aims to build a patient registry for certain areas of fibrotic disease to both increase understanding of natural disease progression, and fuel biomarker discovery. Pliant’s co-founders include world-renowned researchers from University of California, San Francisco (UCSF), who bring broad experience in fibrosis biology and small molecule chemistry. Together, the Pliant team is dedicated to translating scientific advances in fibrosis biology into novel therapies for patients in need.

pliantrx.com

Company Details

Founded

2016

Employees

Between 100 - 500 employees

Raised

$694,945,152

Headquarters Location

Redwood City, CA

Public

Yes

Acquired

No

CEO

Bernard CoulieBernard Coulie

Founders

Dean Sheppard
Dean Sheppard
William DeGrado
William DeGrado
Bradley Backes
Bradley Backes
Hal Chapman
Hal Chapman

Company Collections

These are collections Pliant Therapeutics is a part of. Click on the collection name to view similar companies.

Pliant Therapeutics' Investors

Pliant Therapeutics' Tech Stack